Why Attend the NORD Breakthrough Summit?

Join thought-leaders in discussing solutions to the most pressing issues facing the rare disease community, such as:

The Sustainability of Rare Disease Drug Development
Impact of the Inflation Reduction Act
Gene-Editing
Artificial Intelligence (AI) and Digital Health
Moving DEI from Good Intentions into Effective Action

The NORD Rare Diseases and Orphan Products Breakthrough Summit® offers an unparalleled opportunity to discuss complex, multi-faceted topics with all rare disease stakeholders– medical and academic experts, regulators and policymakers, innovators, patients, caregivers, and industry leaders.

Relevant and Dynamic Agenda

Sessions offering real-world, actionable information on critical topics such as:

Accelerated Approval
Pediatric Orphan Drug Development
Non-traditional Clinical Trials
Orphan Product Investment
Drug Repurposing
Mental Health and Rare Diseases

Network with Influencers and Rare Disease Community Stakeholders

Forge meaningful connections and collaborate with influential stakeholders across the rare disease community.

Take advantage of 1:1 networking meetings — Meetings can be scheduled through the event App. Details will be shared via email when the app opens ahead of the event.
Roundtable discussion groups
Join fellow attendees at the Welcome Reception on Sunday, October 15
Engage with others during the Poster Hall and Exhibit Hall Reception on Monday, October 16
Connect face-to-face and build relationships with 60+ sponsors and exhibitors

Opportunities to Learn About Research and Public Health Projects

View 80+ posters from fellow academics, researchers, industry, government agencies, healthcare professionals, patient organizations, and students. The top five selected poster abstracts will be presented on the main stage during lightning round presentations on Monday, October 16 at 4:30 p.m.

Who Attends?

The NORD Breakthrough Summit audience encompasses a wide range of key stakeholders involved in rare disease.

Join over 900 rare disease advocates, experts, and stakeholders from around the world to tackle the most pressing issues facing the rare disease community.